1. Compared to the 50-day high, the shares are 0.74 percent below this figure.
2. The shares are 21.15 percentage points away from its 50-day moving average and 16.51 percent away from its 200-day moving average, the Winfield Review reports.
3. Among analysts covering the stock, they have a 1.7 rating, with one indicating a “strong buy” and five indicating a “strong sell.”
4. The Street’s price target totals $21.20 for Surgery Partners shares.
5. Surgery Partners shares traded at $20.25 on Feb. 11, 2017.
More articles on surgery centers:
9 joint ventures ASC in January/ February
HSS, Stamford Health partner on ASC; Expect to have 400+ ambulatory cases by year’s end
Bay Area Regional Medical Center, Medistar team up on ASC — 4 things to know
